Technology Landscape on “BBB/CNS Delivery”
Problem & Context: The blood-brain barrier (BBB) has been a great hurdle for brain drug delivery. The blood-brain barrier (BBB) represents a major obstacle to the delivery of drugs to the central nervous system (CNS). The presence of BBB delivery technology allows for engineering the therapeutic to enable entry into the brain across the BBB [...]
Technology Landscape on “Non-viral RNA Delivery”
Problem & Context: Non-viral RNA drug delivery technologies such as mRNA drug delivery technologies are associated with biosafety, low immunogenic response, high loading capacity and versatility. These cover a wide range of possibilities from the most advanced LNPs to polymeric, protein-based systems, hybrid, and even endogenous EVs. SciTech Patent Art conducted a technology landscape study [...]
Technology Landscape on “Targeted delivery”
Problem & Context: Targeted delivery technologies such as Tumor targeting technologies will solve the tumor specificity issues associated with conventional cancer chemotherapy. SciTech Patent Art conducted a technology landscape study to identify various drug delivery and device technologies with specific focus on companies engaged in early development, clinical evaluation, or commercialization of tumor targeting technologies. [...]
Technology Landscape on “Sustained release delivery“
Problem & Context: Non-viral RNA drug delivery technologies such as mRNA drug delivery technologies are associated with biosafety, low immunogenic response, high loading capacity and versatility. These cover a wide range of possibilities from the most advanced LNPs to polymeric, protein-based systems, hybrid, and even endogenous EVs. SciTech Patent Art conducted a technology landscape study [...]